A Phase 1 Study of Single Agent Veliparib in Japanese Subjects With Advanced Solid Tumors

Clinical trial NCT02210663 · COMPLETED

Trial details

NCT number: NCT02210663
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2014-07-01
Primary completion: 2016-01-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.